Location History:
- Craigavon Armagh, GB (2017)
- Armagh, GB (2020)
- Craigavon, GB (2013 - 2023)
Company Filing History:
9 out of 12 
1 out of 1 
1 out of 1 Years Active: 2013-2025
Title: The Innovative Contributions of Frank Burkamp
Introduction
Frank Burkamp is a notable inventor based in Craigavon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological processes. With a total of 10 patents to his name, Burkamp's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, Burkamp has developed 4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19). These inhibitors are crucial in the treatment of conditions such as muscular atrophy, obesity, insulin resistance, and type II diabetes. Additionally, he has patented pyrimidopyrimidinones that serve as Wee-1 kinase inhibitors, which are valuable in cancer treatment. These compounds are designed to inhibit the activity of Wee-1 kinase, offering new avenues for pharmaceutical compositions and therapeutic methods.
Career Highlights
Throughout his career, Frank Burkamp has worked with prominent companies, including Almac Discovery Limited and Almac House. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Burkamp has collaborated with notable colleagues such as Colin O'Dowd and James Samuel Shane Rountree. These partnerships have fostered innovation and have been instrumental in advancing his research projects.
Conclusion
Frank Burkamp's innovative work and numerous patents highlight his significant role in the pharmaceutical field. His contributions have the potential to lead to important advancements in medical treatments and therapies.